Literature DB >> 32340745

Iron: The cancer connection.

Suzy V Torti1, Frank M Torti2.   

Abstract

Iron plays an essential role in normal biological processes: The generation of cellular energy, oxygen transport, DNA synthesis and repair are all processes that require iron-coordinated proteins, either as elemental iron, heme or iron-sulfur clusters. As a transition metal with two major biological oxidation states, iron is also a critical intermediate in the generation of reactive oxygen species that can damage cellular structures and contribute to both aging and cancer. In this review, we focus on experimental and epidemiologic evidence that links iron and cancer, as well as strategies that have been proposed to either reduce or increase cellular iron for cancer therapy.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ferroportin; Ferroptosis; Iron chelator; Metastasis; Transferrin receptor

Mesh:

Substances:

Year:  2020        PMID: 32340745      PMCID: PMC9107937          DOI: 10.1016/j.mam.2020.100860

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  109 in total

1.  Promotion of dimethylbenz[a]anthracene-initiated mammary carcinogenesis by iron in female Sprague-Dawley rats.

Authors:  B A Diwan; K S Kasprzak; L M Anderson
Journal:  Carcinogenesis       Date:  1997-09       Impact factor: 4.944

2.  Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis.

Authors:  Kathryn A O'Donnell; Duonan Yu; Karen I Zeller; Jung-Whan Kim; Frederick Racke; Andrei Thomas-Tikhonenko; Chi V Dang
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

3.  Transcriptional regulation of the cyclin-dependent kinase inhibitor, p21CIP1/WAF1, by the chelator, Dp44mT.

Authors:  Rayan S Moussa; Zaklina Kovacevic; Dong-Hun Bae; Darius J R Lane; Des R Richardson
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-10-13       Impact factor: 3.770

4.  Antitumor effect of deferoxamine on human hepatocellular carcinoma growing in athymic nude mice.

Authors:  H W Hann; M W Stahlhut; R Rubin; W C Maddrey
Journal:  Cancer       Date:  1992-10-15       Impact factor: 6.860

5.  Effect of dietary iron deficiency or excess on the induction of mammary carcinogenesis by 1-methyl-1-nitrosourea.

Authors:  H J Thompson; K Kennedy; M Witt; J Juzefyk
Journal:  Carcinogenesis       Date:  1991-01       Impact factor: 4.944

6.  An IgG1 Version of the Anti-transferrin Receptor 1 Antibody ch128.1 Shows Significant Antitumor Activity Against Different Xenograft Models of Multiple Myeloma: A Brief Communication.

Authors:  Tracy R Daniels-Wells; Pierre V Candelaria; Lai Sum Leoh; Miguel Nava; Otoniel Martínez-Maza; Manuel L Penichet
Journal:  J Immunother       Date:  2020 Feb/Mar       Impact factor: 4.912

7.  Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide.

Authors:  Sang-Soo Kim; Joe B Harford; Manish Moghe; Antonina Rait; Kathleen F Pirollo; Esther H Chang
Journal:  Nucleic Acids Res       Date:  2018-02-16       Impact factor: 16.971

8.  Disruption of FBXL5-mediated cellular iron homeostasis promotes liver carcinogenesis.

Authors:  Yoshiharu Muto; Toshiro Moroishi; Kazuya Ichihara; Masaaki Nishiyama; Hideyuki Shimizu; Hidetoshi Eguchi; Kyoji Moriya; Kazuhiko Koike; Koshi Mimori; Masaki Mori; Yuta Katayama; Keiichi I Nakayama
Journal:  J Exp Med       Date:  2019-03-15       Impact factor: 14.307

9.  The iron load of lipocalin-2 (LCN-2) defines its pro-tumour function in clear-cell renal cell carcinoma.

Authors:  Claudia Rehwald; Matthias Schnetz; Anja Urbschat; Christina Mertens; Julia K Meier; Rebekka Bauer; Patrick Baer; Sofia Winslow; Frederik C Roos; Klaus Zwicker; Arnaud Huard; Andreas Weigert; Bernhard Brüne; Michaela Jung
Journal:  Br J Cancer       Date:  2019-11-27       Impact factor: 7.640

10.  Contribution of three-dimensional architecture and tumor-associated fibroblasts to hepcidin regulation in breast cancer.

Authors:  Nicole Blanchette-Farra; Daniel Kita; Anna Konstorum; Lia Tesfay; David Lemler; Poornima Hegde; Kevin P Claffey; Frank M Torti; Suzy V Torti
Journal:  Oncogene       Date:  2018-04-26       Impact factor: 9.867

View more
  20 in total

1.  Global miRNA/proteomic analyses identify miRNAs at 14q32 and 3p21, which contribute to features of chronic iron-exposed fallopian tube epithelial cells.

Authors:  Ravneet Chhabra; Stephanie Rockfield; Jennifer Guergues; Owen W Nadeau; Robert Hill; Stanley M Stevens; Meera Nanjundan
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

Review 2.  Persister cancer cells: Iron addiction and vulnerability to ferroptosis.

Authors:  Raphaël Rodriguez; Stuart L Schreiber; Marcus Conrad
Journal:  Mol Cell       Date:  2021-12-28       Impact factor: 19.328

3.  A new survival model based on ferroptosis-related genes for prognostic prediction in clear cell renal cell carcinoma.

Authors:  Guangzhen Wu; Qifei Wang; Yingkun Xu; Quanlin Li; Liang Cheng
Journal:  Aging (Albany NY)       Date:  2020-07-20       Impact factor: 5.682

4.  Iron Supplementation Interferes With Immune Therapy of Murine Mammary Carcinoma by Inhibiting Anti-Tumor T Cell Function.

Authors:  Piotr Tymoszuk; Manfred Nairz; Natascha Brigo; Verena Petzer; Simon Heeke; Brigitte Kircher; Natascha Hermann-Kleiter; Victoria Klepsch; Igor Theurl; Günter Weiss; Christa Pfeifhofer-Obermair
Journal:  Front Oncol       Date:  2020-12-04       Impact factor: 6.244

5.  Consequences of NaCT/SLC13A5/mINDY deficiency: good versus evil, separated only by the blood-brain barrier.

Authors:  Jonathan J Kopel; Yangzom D Bhutia; Sathish Sivaprakasam; Vadivel Ganapathy
Journal:  Biochem J       Date:  2021-02-12       Impact factor: 3.857

6.  The iron chelator deferoxamine decreases myeloma cell survival.

Authors:  Feifei Yang; Zhaoxian Wu; Dan Dai; Lei Zhang; Xiuqun Zhang; Xuezhong Zhang; Yanli Xu
Journal:  J Int Med Res       Date:  2021-01       Impact factor: 1.671

Review 7.  Iron Dysregulation in Human Cancer: Altered Metabolism, Biomarkers for Diagnosis, Prognosis, Monitoring and Rationale for Therapy.

Authors:  Pierre Lelièvre; Lucie Sancey; Jean-Luc Coll; Aurélien Deniaud; Benoit Busser
Journal:  Cancers (Basel)       Date:  2020-11-26       Impact factor: 6.639

Review 8.  Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents.

Authors:  Pierre V Candelaria; Lai Sum Leoh; Manuel L Penichet; Tracy R Daniels-Wells
Journal:  Front Immunol       Date:  2021-03-17       Impact factor: 7.561

Review 9.  Pancreatic Ductal Adenocarcinoma: The Dawn of the Era of Nuclear Medicine?

Authors:  Christopher Montemagno; Shamir Cassim; Nicolas De Leiris; Jérôme Durivault; Marc Faraggi; Gilles Pagès
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

Review 10.  Emerging mechanisms and targeted therapy of ferroptosis in cancer.

Authors:  Haiyan Wang; Yan Cheng; Chao Mao; Shuang Liu; Desheng Xiao; Jun Huang; Yongguang Tao
Journal:  Mol Ther       Date:  2021-03-29       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.